Haleon (HLN) Invested Capital (2021 - 2025)
Haleon (HLN) posted Invested Capital of $1.1 billion for Q4 2025, down 41.74% on a QoQ basis from $1.9 billion in Q4 2024, and down 41.74% year-over-year from $1.9 billion in Q4 2024.
Haleon (HLN) Invested Capital (2021 - 2025) Analysis & Trends
Haleon's Invested Capital history runs 5 years deep, the most recent figure standing at $1.1 billion for Q4 2025.
- Quarterly Invested Capital fell 41.74% year-over-year to $1.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.8 billion (up 40.84% YoY) and the FY2025 annual result came in at $1.1 billion, down 42.01% from the prior year.
- Invested Capital was $1.1 billion for Q4 2025 at Haleon, down from $1.9 billion in the prior quarter.
- Across five years, Invested Capital topped out at $1.9 billion in Q4 2024 and bottomed at $2.7 million in Q4 2021.
- A 5-year average of $770.1 million and a median of $814.2 million in 2023 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2023 — Invested Capital surged 6210.51% — and 2025, when it tumbled 41.74%.
- Haleon's Invested Capital stood at $2.7 million in 2021, then soared by 378.56% to $12.9 million in 2022, then surged by 6210.51% to $814.2 million in 2023, then surged by 134.41% to $1.9 billion in 2024, then tumbled by 41.74% to $1.1 billion in 2025.
- Business Quant data shows HLN's Invested Capital at $1.1 billion in Q4 2025, $1.9 billion in Q4 2024, and $814.2 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.11 Bn |
| Dec 31, 2024 | 1.91 Bn |
| Dec 31, 2023 | 814.20 Mn |
| Dec 31, 2022 | 12.90 Mn |
| Dec 31, 2021 | 2.70 Mn |